Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis
Restricted accessResearch articleFirst published online August, 2021
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis
Systemic lupus erythematosus (SLE) increases the incidence of adverse pregnancy outcomes (APOs). Nevertheless, most of the data on SLE pregnancies were derived from database studies in which details of the pregnancies were unavailable, and no consensus exists on the risk of APO in patients with prior severe organ manifestations.
Methods
SLE patients followed by rheumatologists and gynecologists throughout pregnancy at our institute were retrospectively identified, and their data between April 2003 and December 2020 were reviewed from electronic records. We assigned patients based on the presence of prior severe organ manifestation (renal/neurological manifestation, prior treatment with methylprednisolone pulse therapy/prednisolone 1 mg/kg/day/biological or cytotoxic therapy) and compared the incidence of overall and serious APO (maternal death, pregnancy loss, preterm birth <32 weeks, birthweight <1500 g, Apgar score <7 at 5 min and birth defect).
Results
This study included 34 pregnancies in 32 patients; 23 pregnancies in 22 patients were classified as SLE with prior severe organ manifestation. There was no statistical difference in the incidence of overall APO between the two groups (52.2% vs 45.5%, P = 1). Among patients with prior severe organ manifestation, 17.4% had serious APO. A detailed electronic health record search revealed specific causes of APO in all pregnancies with serious APO, except the presence of prior severe organ manifestation.
Conclusion
The incidence of overall APO in SLE patients was not affected by prior severe organ manifestation. Although the incidence of serious APOs increased in patients with previous severe organ manifestation, there were other risk factors for poor pregnancy outcomes besides prior lupus severity. Therefore, proper management by rheumatologists and gynecologists may enable patients with prior severe organ manifestation to safely deliver healthy babies.
ClowseMEBChakravartyECostenbaderKHChambersCMichaudK.Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken)2012;
64: 668–674.
2.
ClowseMEBJamisonMMyersEJamesAH.A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol2008;
199: 127.e1–6.
3.
CavallascaJALabordeHARuda-VegaHNasswetterGG.Maternal and fetal outcomes of 72 pregnancies in argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol2008;
27: 41–46.
4.
BuyonJPKimMYGuerraMM, et al.
Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med2015;
163: 153–163.
5.
ClowseMEBMagderLSWitterFPetriM.The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum2005;
52: 514–521.
6.
ChakravartyEFSammaritanoLR. Pregnancy and autoimmune disease, reproductive and hormonal issues. In: Wallace D and Hahn B (eds) Dubois’ Lupus Erythematosus and Related Syndromes. 9th ed. Amsterdam: Elsevier, 2018, pp.499–519.
7.
SammaritanoLRBermasBLChakravartyEE, et al.
2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol2020;
72: 529–556.
8.
AttiaDHMokbelAHaggagHMNaeemN.Pregnancy outcome in women with active and inactive lupus nephritis: a prospective cohort study. Lupus2019;
28: 806–817.
9.
HochbergMC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997;
40: 1725–1734.
10.
PetriMOrbaiAMAlarcõnGS, et al.
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012;
64: 2677–2686.
11.
AringerMCostenbaderKDaikhD, et al.
European League against Rheumatism/American College of Rheumatology Classification Criteria for systemic lupus erythematosus. Arthritis Rheumatol2019;
71: 1400–1412.
12.
SudaMKishimotoMOhdeS, et al.
Validation of the 2019 ACR/EULAR classification criteria of systemic lupus erythematosus in 100 Japanese patients: a real-world setting analysis. Clin Rheumatol2020;
39: 1823–1827.
13.
BarfieldWD.Public health implications of very preterm birth. Clin Perinatol2018;
45: 565–577.
14.
LøhaugenGCCGramstadAEvensenKAI, et al.
Cognitive profile in young adults born preterm at very low birthweight. Dev Med Child Neurol2010;
52: 1133–1138.
15.
EhrensteinVPedersenLGrijotaMNielsenGLRothmanKJSørensenH.Association of Apgar score at 5 min with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts. BMC Pregnancy Childbirth2009;
9: 1–7.
16.
SkorpenCGHoeltzenbeinMTincaniA, et al.
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis2016;
75: 795–810.
17.
WangYYangM.Long commutes to work during pregnancy and infant health at birth. Econ Hum Biol2019;
35: 1–17.
18.
PasternakBHviidA.Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med2010;
363: 2114–2123.
19.
WuJMaJBaoCDiWZhangWH.Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study. BMJ Open2018;
8: e020909.
20.
ChenCYChenYHLinHCChenSFLinHC.Increased risk of adverse pregnancy outcomes for hospitalisation of women with lupus during pregnancy: a nationwide population-based study. Clin Exp Rheumatol2010;
28: 49–55.
21.
McGroryCHMcCloskeyLJDeHoratiusRJDunnSRMoritzMJArmentiVT.Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant2003;
3: 35–42.
22.
MehtaBLuoYXuJ, et al.
Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States. Ann Intern Med2019;
171: 164–171.
23.
LingNLawsonEvon SchevenE.Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate. Pediatr Rheumatol2018;
16: 5–10.
24.
Marx-DeseureALabreucheJLaunayDDepretSSubtilD.Are pregnancies with lupus but without APS of good prognosis?Autoimmun Rev2020;
19: 102489.
25.
VinetÉPineauCAClarkeAE, et al.
Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population-based cohort. Arthritis Rheumatol2015;
67: 3201–3208.
26.
VinetÉPineauCAScottSClarkeAEPlattRWBernatskyS.Increased congenital heart defects in children born to women with systemic lupus erythematosus results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study. Circulation2015;
131: 149–156.
27.
Sugiura-OgasawaraMEbaraTYamadaY, Japan Environment, Children’s Study (JECS) Groupet al.
Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children's Study. Am J Reprod Immunol2019;
81: e13072.
28.
KroeseSJDe HairMJHLimperM, et al.
Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in preterm births. J Immunol Res2017;
2017: 2810202.
29.
TsudaSSameshimaASekineM, for The Ministry of Health Labour and Welfare Working Group for “Guideline for The Treatment of Rheumatoid Arthritis or Inflammatory Bowel Disease Bearing Women in Child-bearing Age”et al.
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study. Mod Rheumatol2020;
30: 852–861.
30.
KuMGuoSShangW, et al.
Pregnancy outcomes in Chinese patients with systemic lupus erythematosus (SLE): a retrospective study of 109 pregnancies. PLoS One2016;
11: e0159364.
31.
Palma dos ReisCRCardosoGCarvalhoCNogueiraIBorgesASerranoF.Prediction of adverse pregnancy outcomes in women with systemic lupus erythematosus. Clin Rev Allergy Immunol2020;
59: 287–294.
32.
PastoreDEACostaMLSuritaFG.Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes. Lupus2019;
28: 1417–1426.
33.
ChenDLaoMZhangJ, et al.
Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study. J Immunol Res2018;
2018: 2413637.
34.
DavutoğluEAOzelAYılmazNMadazliR.Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey. Arch Gynecol Obstet2017;
296: 1079–1084.
35.
TedeschiSKGuanHFineACostenbaderKHBermasB.Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes. Clin Rheumatol2016;
35: 1725–1732.
36.
ChenDLaoMCaiX, et al.
Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study. Clin Rheumatol2019;
38: 3501–3509.
37.
EudyAMSiega-RizAMEngelSM, et al.
Preconceptional cardiovascular health and pregnancy outcomes in women with systemic lupus erythematosus. J Rheumatol2019;
46: 70–77.
38.
ArkemaEVPalmstenKSjöwallCSvenungssonESalmonJESimardJF.What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and Pre-SLE. Arthritis Care Res (Hoboken)2016;
68: 988–994.
39.
BandoliGSinghNStrouseJ, et al.
Mediation of adverse pregnancy outcomes in autoimmune conditions by pregnancy complications: a mediation analysis of autoimmune conditions and adverse pregnancy outcomes. Arthritis Care Res2020;
72: 256–264.
40.
Davis-PoradaJKimMYGuerraMM, et al.
Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther2020;
22: 1–8.
41.
WilliamsAGrantzKSeeniI, et al.
Obstetric and neonatal complications among women with autoimmune disease. J Autoimmun2019;
103: 102287.
42.
SaavedraMÁMiranda-HernándezDSánchezA, et al.
Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study. Rheumatol Int2016;
36: 1431–1437.
43.
GalappatthyPJayasingheJDDPaththinigeSCSheriffRMHWijayaratneLS.Pregnancy outcomes and contraceptive use in patients with systemic lupus erythematosus, rheumatoid arthritis and women without a chronic illness: a comparative study. Int J Rheum Dis2017;
20: 746–754.
44.
ClowseMEBGrotegutC.Racial and ethnic disparities in the pregnancies of women with systemic lupus erythematosus. Arthritis Care Res (Hoboken)2016;
68: 1567–1572.
45.
VinetÉGenestGScottS, et al.
Brief report: Causes of stillbirths in women with systemic lupus erythematosus. Arthritis Rheumatol2016;
68: 2487–2491.
46.
TehCLWanSACheongYKLingGR.Systemic lupus erythematosus pregnancies: ten-year data from a single centre in Malaysia. Lupus2017;
26: 218–223.
47.
OhyamaATsuboiHNomaH, et al.
Associations between maternal clinical features and fetal outcomes in pregnancies of mothers with connective tissue diseases. Mod Rheumatol2019;
29: 344–350.
48.
ZhanZYangYZhanYChenDLiangLYangX.Fetal outcomes and associated factors of adverse outcomes of pregnancy in Southern Chinese women with systemic lupus erythematosus. PLoS One2017;
12: e0176457.
49.
JanardanaRHaridasVPriyaV, et al.
Maternal and fetal outcomes of lupus pregnancies: a collective effort by Karnataka rheumatologists. Lupus2020;
29: 1397–1403.
50.
KimIJKimHASuhCH, et al.
Impact of childbearing decisions on family size of Korean women with systemic lupus erythematosus. J Korean Med Sci2016;
31: 729–734.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
